Outcome of Allogeneic Hematopoietic Stem Cell Transplantation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation — Stella

Home/Hematopoietic Stem Cell Transplant (HSCT)/

View on ClinicalTrials.gov

Recruiting

Back to Hematopoietic Stem Cell Transplant (HSCT) trials

Trial locations(2 sites)

Hong Kong

Department of Medicine, Queen Mary Hospital, Hong Kong

Queen Mary Hospital, Hong Kong, Hong Kong

Key details

Sponsor

The University of Hong Kong

Enrollment target

~1,000 participants

Started

December 2024

Primary completion

December 2029

Age range

18 Years and older

Last updated November 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.